{"id":"https://openalex.org/W2019802783","doi":"https://doi.org/10.4103/0253-7613.24614","title":"Development of new incretin drugs: Promising therapies","display_name":"Development of new incretin drugs: Promising therapies","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2019802783","doi":"https://doi.org/10.4103/0253-7613.24614","mag":"2019802783"},"language":"en","primary_location":{"id":"doi:10.4103/0253-7613.24614","doi":"https://doi.org/10.4103/0253-7613.24614","is_oa":false,"landing_page_url":"https://doi.org/10.4103/0253-7613.24614","pdf_url":null,"source":{"id":"https://openalex.org/S112348374","display_name":"Indian Journal of Pharmacology","issn_l":"0253-7613","issn":["0253-7613","1998-3751"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Indian Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://www.bioline.org.br/abstract?id=ph06026","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012835084","display_name":"Kirandeep Kaur","orcid":"https://orcid.org/0000-0001-8530-9493","observed_orcids":["https://orcid.org/0000-0001-8530-9493"]},"institutions":[{"id":"https://openalex.org/I4210098996","display_name":"Government Medical College and Hospital","ror":"https://ror.org/010gbda42","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210098996"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Kirandeep Kaur","raw_affiliation_strings":["Department of Pharmacology, Government Medical College and Hospital, Chandigarh-160032, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Government Medical College and Hospital, Chandigarh-160032, India","institution_ids":["https://openalex.org/I4210098996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111029017","display_name":"CS Gautam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098996","display_name":"Government Medical College and Hospital","ror":"https://ror.org/010gbda42","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210098996"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"CS Gautam","raw_affiliation_strings":["Department of Pharmacology, Government Medical College and Hospital, Chandigarh-160032, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Government Medical College and Hospital, Chandigarh-160032, India","institution_ids":["https://openalex.org/I4210098996"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210098996"],"apc_list":null,"apc_paid":null,"fwci":0.3623,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.65328398,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"2","first_page":"100","last_page":"100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.8080000281333923},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8050000071525574},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.8930000066757202},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.9309999942779541},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8230000138282776},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.968999981880188},{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.6150000095367432},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.6880000233650208},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8259999752044678},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.8943387269973755},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.8249168395996094},{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.7913243174552917},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7432282567024231},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5806699991226196},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5711841583251953},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5478196144104004},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.46636924147605896},{"id":"https://openalex.org/C2778854520","wikidata":"https://www.wikidata.org/wiki/Q418776","display_name":"Sulfonylurea","level":3,"score":0.451631635427475},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.4486786723136902},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.44656848907470703},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42129233479499817},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3798183798789978},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3797442615032196},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.35431262850761414},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3480229675769806}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.4103/0253-7613.24614","doi":"https://doi.org/10.4103/0253-7613.24614","is_oa":false,"landing_page_url":"https://doi.org/10.4103/0253-7613.24614","pdf_url":null,"source":{"id":"https://openalex.org/S112348374","display_name":"Indian Journal of Pharmacology","issn_l":"0253-7613","issn":["0253-7613","1998-3751"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Indian Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:cria:bioline:ph:ph06026","doi":null,"is_oa":true,"landing_page_url":"http://www.bioline.org.br/abstract?id=ph06026","pdf_url":"http://www.bioline.org.br/abstract?id=ph06026","source":{"id":"https://openalex.org/S4306402188","display_name":"Bioline International (Bioline International)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Indian Journal of Pharmacology (ISSN: 0253-7613) Vol 38 Num 2","raw_type":"AA"},{"id":"pmh:oai:utoronto.scholaris.ca:1807/8773","doi":null,"is_oa":false,"landing_page_url":"http://www.bioline.org.br/abstract?id=ph06026","pdf_url":null,"source":{"id":"https://openalex.org/S4306400261","display_name":"TSpace (University of Toronto)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I185261750","host_organization_name":"University of Toronto","host_organization_lineage":["https://openalex.org/I185261750"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"mag:2319899567","doi":null,"is_oa":false,"landing_page_url":"http://www.bioline.org.br/pdf?ph06026","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:cria:bioline:ph:ph06026","doi":null,"is_oa":true,"landing_page_url":"http://www.bioline.org.br/abstract?id=ph06026","pdf_url":"http://www.bioline.org.br/abstract?id=ph06026","source":{"id":"https://openalex.org/S4306402188","display_name":"Bioline International (Bioline International)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Indian Journal of Pharmacology (ISSN: 0253-7613) Vol 38 Num 2","raw_type":"AA"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2019802783.pdf","grobid_xml":"https://content.openalex.org/works/W2019802783.grobid-xml"},"referenced_works_count":63,"referenced_works":["https://openalex.org/W1507814807","https://openalex.org/W1905803407","https://openalex.org/W1952505253","https://openalex.org/W1964854428","https://openalex.org/W1973351394","https://openalex.org/W1978953702","https://openalex.org/W1979535675","https://openalex.org/W1980130009","https://openalex.org/W1984740259","https://openalex.org/W1986085856","https://openalex.org/W1990991299","https://openalex.org/W1991434889","https://openalex.org/W2000465889","https://openalex.org/W2003141714","https://openalex.org/W2004507897","https://openalex.org/W2004977380","https://openalex.org/W2005334239","https://openalex.org/W2016732441","https://openalex.org/W2022964894","https://openalex.org/W2024058025","https://openalex.org/W2024409703","https://openalex.org/W2025204456","https://openalex.org/W2028479574","https://openalex.org/W2030684076","https://openalex.org/W2051743127","https://openalex.org/W2054564814","https://openalex.org/W2061862376","https://openalex.org/W2063693981","https://openalex.org/W2064129538","https://openalex.org/W2064492226","https://openalex.org/W2079644358","https://openalex.org/W2080959651","https://openalex.org/W2082070432","https://openalex.org/W2082604269","https://openalex.org/W2089109393","https://openalex.org/W2095959590","https://openalex.org/W2096716906","https://openalex.org/W2097018460","https://openalex.org/W2100614900","https://openalex.org/W2101613382","https://openalex.org/W2101718966","https://openalex.org/W2108771199","https://openalex.org/W2111482319","https://openalex.org/W2114762146","https://openalex.org/W2115306377","https://openalex.org/W2121827210","https://openalex.org/W2125168546","https://openalex.org/W2126918525","https://openalex.org/W2136254957","https://openalex.org/W2142414068","https://openalex.org/W2143014102","https://openalex.org/W2143847100","https://openalex.org/W2146333376","https://openalex.org/W2147817624","https://openalex.org/W2150092844","https://openalex.org/W2153568541","https://openalex.org/W2161231838","https://openalex.org/W2164961795","https://openalex.org/W2168552871","https://openalex.org/W2170232513","https://openalex.org/W2171529191","https://openalex.org/W2171779326","https://openalex.org/W2210168738"],"related_works":["https://openalex.org/W2058675165","https://openalex.org/W2082032596","https://openalex.org/W1991825295","https://openalex.org/W2162413992","https://openalex.org/W2140491874","https://openalex.org/W1902646265","https://openalex.org/W2765585416","https://openalex.org/W2087825440","https://openalex.org/W7048609817","https://openalex.org/W1999206977"],"abstract_inverted_index":{"New":[0],"agents":[1],"are":[2,84,101,199],"being":[3,21,102],"added":[4],"to":[5,48,81,205,221],"the":[6,12,49,115,163],"armamentarium":[7],"of":[8,14,51,57,61,79,93,99,108,153,157,173,183,193,202,211,226,231],"drugs":[9],"used":[10],"for":[11,118,165],"treatment":[13,132],"diabetes":[15,125],"mellitus.":[16],"Today,":[17],"extensive":[18],"research":[19],"is":[20,175,185,218],"conducted":[22],"on":[23],"incretin":[24,189],"hormones.":[25],"Important":[26],"among":[27],"them":[28],"are,":[29],"Glucagon":[30],"like":[31],"peptide-1":[32],"(GLP-1)":[33],"and":[34,76,95,97,135,149,155,191,228],"Glucose":[35],"dependent":[36],"insulinotropic":[37],"peptide":[38],"(GIP).":[39],"The":[40,181],"gastrointestinal":[41,196],"tract":[42],"secretes":[43],"these":[44,188],"hormones":[45,54],"in":[46,120],"response":[47],"ingestion":[50],"nutrients.":[52],"These":[53],"increase":[55],"secretion":[56,60],"insulin,":[58],"decrease":[59,63,73],"glucagon,":[62],"gastric":[64],"emptying":[65],"time":[66],"(only":[67],"by":[68,87,114,162],"GLP-1).":[69],"In":[70],"addition,":[71],"they":[72],"body":[74],"weight":[75],"prevent":[77],"development":[78],"resistance":[80],"insulin.":[82],"They":[83],"rapidly":[85],"degraded":[86],"dipeptidyl":[88],"peptidase":[89],"(DPP-IV)":[90],"enzyme.":[91],"Analogs":[92,201],"GLP-1":[94,141,203,227],"GIP":[96,154],"inhibitors":[98,192,210,230],"DPP-IV":[100,158,212],"synthesised.":[103],"Exenatide,":[104],"a":[105,138,219],"synthetic":[106],"analog":[107,152],"GLP-1,":[109],"has":[110],"recently":[111],"been":[112,160],"approved":[113,161],"FDA,":[116],"USA":[117],"use":[119,167],"patients":[121],"with":[122,133,187],"type":[123],"2":[124,178],"who":[126],"have":[127,159,204],"sub":[128],"optimal":[129],"control":[130],"despite":[131],"metformin":[134],"/":[136],"or":[137],"sulfonylurea.":[139],"Other":[140],"analogs":[142,225],"under":[143,176],"clinical":[144,166,179],"trial":[145],"are:":[146],"NN2211,":[147],"CJC1131,":[148],"Albugon.":[150],"No":[151],"inhibitor":[156,172],"FDA":[164],"till":[168],"now.":[169],"Vildagliptin,":[170],"an":[171],"DPP-IV,":[174],"phase":[177],"trials.":[180],"incidence":[182],"hypoglycemia":[184],"less":[186],"mimetics":[190],"DPP-IV.":[194,232],"Minimal":[195],"side":[197],"effects":[198],"seen.":[200],"be":[206,214],"given":[207,215],"subcutaneously,":[208],"while":[209],"can":[213],"orally.":[216],"There":[217],"need":[220],"synthesise":[222],"long":[223],"acting":[224],"selective":[229]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}